SAN DIEGO, July 05, 2023 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced the acquisition of privately held Somnoware, a U.S. leader in sleep and respiratory care diagnostics software.

SUNNYVALE, Calif., June 5, 2019 /PRNewswire-PRWeb/ -- Somnoware, a leading provider of digital health technology, is excited to share some important insights from Irene Dilinila's recent speech at the ...

ResMed RMD recently announced the acquisition of Somnoware — the renowned, privately held, sleep and respiratory care diagnostics software provider in the United States. The partnership will enable ...

Resmed Inc. has acquired Somnoware Inc., a privately held developer of respiratory care diagnostics software, for an undisclosed price. The deal is Resmed’s third software acquisition in the past year ...

CerraCap Ventures announces its investment in Somnoware, a web-based platform transforming respiratory healthcare and revolutionizing chronic care management. COSTA MESA, Calif., May 12, 2022 ...

Charlotte, North Carolina-based Somnoware, which offers a sleep management software system, has raised $9 million in a round led by TransLink Capital with participation from World Innovation Lab (WiL) ...

Expands ResMed’s sleep management software solution, will help sleep labs and physicians more efficiently guide patients into and through diagnosis to long-term treatment Diagnostic management ...